The Combating Autism Act: Elements, Funding and Analyses

$140.00

Deryck Harlow (Editor)

Series: Neurodegenerative Diseases – Laboratory and Clinical Research
BISAC: POL019000

Autism spectrum disorder (ASD) and autism are general terms for a group of developmental disabilities that cause impairments in social skills and communication, and are often characterized by certain atypical behaviors. The federal government has a role in the financing (through Medicaid and State Children’s Health Insurance Programs) and delivery of treatment for ASD. The number of autism cases and their appropriate diagnosis and treatment affect federal and state expenditures. As such, Congress has shown interest in financing research on ASD prevalence, causes, and optimal treatment for individuals with ASD.

This book presents an overview of the Combating Autism Act and Combating Autism Reauthorization Act, the Department of Health and Human Services funding, other federal activities related to autism, and selected issues for Congress. It also describes the actions that HHS agencies have taken as a result of the CAA; examines the oversight of CAA grantees; analyzes the extent to which federal agencies fund potentially duplicative autism research; and assesses the extent to which IACC and agencies coordinate and monitor federal autism activities. (Imprint: Nova)

 

Clear

Details

Table of Contents

Preface

Chapter 1 – The Combating Autism Act: Overview and Funding (pp. 1-18)
Amalia K. Corby-Edwards

Chapter 2 – Combating Autism Act: HHS Agencies Responded with New and Continuing Activities, Including Oversight (pp. 19-62)
United States Government Accountability Office

Chapter 3 – Federal Autism Activities: Better Data and More Coordination Needed to Help Avoid the Potential for Unnecessary Duplication (pp. 63-140)
United States Government Accountability Office

Index

 

Additional information

Binding

,